Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes: The LADIS (Leukoaraiosis and Disability in the Elderly) study

Cerebrovascular Diseases

Volumn 21, Issue 5-6, 2006, Pages 315-322

  Basile, Anna Maria ^a   Pantoni, Leonardo ^a   Pracucci, Giovanni ^a   Asplund, Kjell ^b   Chabriat, Hugues ^c   Erkinjuntti, Timo ^d   Fazekas, Franz ^e   Ferro, José M ^f   Hennerici, Michael ^g   O'Brien, John ^h   Scheltens, Philip ⁱ   Visser, Marieke C ⁱ   Wahlund, Lars Olof ^j   Waldemar, Gunhild ^k   Wallin, Anders ^l   Inzitari, Domenico ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^c HÔPITAL LARIBOISIÈRE   (France)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF GRAZ   (Austria)

^f Centro de Estudos Egas Moniz   (Portugal)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

ⁱ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k Mental Health Services CPH   (Denmark)

^l UNIVERSITY OF GOTHENBURG   (Sweden)

more..

Author keywords

Hypercholesterolemia; Hypertension; Lacunar infarct; Leukoaraiosis; Smoking; Stroke; White matter changes

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRAIN DAMAGE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; STROKE; WHITE MATTER; BRAIN INFARCTION; DISABILITY; FACTUAL DATABASE; HOSPITALIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

AGE FACTORS; AGED; BRAIN INFARCTION; DATABASES, FACTUAL; DISABILITY EVALUATION; FEMALE; HUMANS; HYPERTENSION; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 33748463827     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091536     Document Type: Article

References (34)

1. Hachinski VC, Potter P, Merskey H: Leukoaraiosis. Arch Neurol 1987;44:21-23.
2. Pantoni L, Garcia JH: The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 1995;26:1293-1301.
3. Inzitari D: Leukoaraiosis: an independent risk factor for stroke? Stroke 2003;34:2067-2071.
4. Pantoni L, Garcia JH: Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-659.
5. Inzitari D, Di Carlo A, Mascalchi M, Pracucci G, Amaducci L: The cardiovascular outcome of patients with motor impairment and extensive leukoaraiosis. Arch Neurol 1995;52:687-691.
6. Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, Hubbard LD, Mosley TH; for the ARIC Investigators: Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288:67-74.
7. Yamauchi H, Fukuda H, Oyanagi C: Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis. J Neurol Neurosurg Psychiatry 2002;72:576-582.
8. Inzitari D, Cadelo M, Marranci ML, Pracucci G, Pantoni L: Vascular deaths in elderly neurological patients with leukoaraiosis. J Neurol Neurosurg Psychiatry 1997;62:177-181.
9. Dufouil C, de Kersaint-Gilly A, Besancon V, Levy C, Auffray E, Brunnereau L, Alperovitch A, Tzourio C: Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology 2001;56:921-926.
10. Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, Tyroler HA: Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996;27:2262-2270.
11. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3,301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-1282.
12. Glynn JR: A question of attribution. Lancet 1993;342:530-532.
13. Pantoni L, Basile AM, Pracucci G, Asplund K, Bogousslavsky J, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D: Impact of age-related cerebral white matter changes on the transition to disability. The LADIS study: rationale, design and methodology. Neuroepidemiology 2005;24:51-62.
14. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
15. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1,5 T in Alzheimer's dementia and normal aging. AJNR Am J Neuroradiol 1987;8:421-426.
16. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines subcommittee. J Hypertens 1999;17:151-185.
17. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-1197.
18. National cholesterol education program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 1994;89:1333-1445.
19. Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined - A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
20. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O'Rourke RA, Schafer WP, Williams SV, Ritchie JL, Cheitlin MD, Eagle KA, Gardner TJ, Garson A Jr, Russell RO, Ryan TJ, Smith SC Jr: ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092-2197.
21. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE 3rd, Steward DE, Theroux P, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC Jr: ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2000;36:970-1062.
22. The Task Force on Heart Failure of the European Society of Cardiology: Guidelines for the diagnosis of heart failure. Eur Heart J 1995;16:741-751.
23. Falk RH: Atrial fibrillation. N Engl J Med 2001;344:1067-1078.
24. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Saekett DL, Strandness DE, Jr, Taylor LM: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996;94:3026-3049.
25. Hatano S: Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976;54:541-553.
26. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
27. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1-96.
28. British Thoracic Society: BTS guidelines for the management of chronic obstructive airways disease. Thorax 1997;52(Suppl 5):S1-S28.
29. Inzitari D, Diaz F, Fox A, Hachinski VC, Steingart A, Lau C, Donald A, Wade J, Mulic H, Merskey H: Vascular risk factors and leukoaraiosis. Arch Neurol 1987;44:42-47.
30. de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J, Breteler MM: Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002;125:765-772.
31. van Dijk EJ, Breteler MM, Schmidt R, Berger K, Nilsson LG, Oudkerk M, Pajak A, Sans S, de Ridder M, Dufouil C, Fuhrer R, Giampaoli S, Launer LJ, Hofman A; for the CASCADE Consortium: The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension 2004;44:625-630.
32. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, DeCarli C: Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004;35:1857-1861.
33. Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, Manolio TA, Lefkowitz D, Jungreis C, Hirsch CH, O'Leary DH, Furberg CD: Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2005;36:56-61.
34. Pantoni L, Sarti C, Pracucci G, Di Carlo A, Vanni P, Inzitari D: Lipoprotein(a) serum levels and vascular diseases in an older Caucasian population cohort. Italian Longitudinal Study on Aging (ILSA). J Am Geriatr Soc 2001;49:117-125.